We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+4.38%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$56.3B
AUM Growth
-$596M
Cap. Flow
-$1.62B
Cap. Flow %
-2.89%
Top 10 Hldgs %
32.29%
Holding
1,743
New
37
Increased
427
Reduced
443
Closed
34

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$374M
2
MSFT icon
Microsoft
MSFT
+$253M
3
AAPL icon
Apple
AAPL
+$200M
4
AVGO icon
Broadcom
AVGO
+$198M
5
META icon
Meta Platforms (Facebook)
META
+$193M

Sector Composition

Rank Sector Weight
1 Technology 29.94%
2 Financials 13.84%
3 Healthcare 12.35%
4 Consumer Discretionary 10.61%
5 Communication Services 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTNX icon
551
Nutanix
NTNX
$16B
$7.19M 0.01%
117,507
+35,209
+43% +$2.3M
KIM icon
552
Kimco Realty
KIM
$17.7B
$7.17M 0.01%
305,955
+67,817
+28% +$1.64M
TMDX icon
553
Transmedics
TMDX
$2.64B
$7.16M 0.01%
114,786
-34,313
-23% -$3.19M
XLF icon
554
State Street Financial Select Sector SPDR ETF
XLF
$57.4B
$7.14M 0.01%
147,714
+25,541
+21% +$1.23M
SUI icon
555
Sun Communities
SUI
$15.3B
$7.12M 0.01%
57,872
-6,614
-10% -$847K
J icon
556
Jacobs Solutions
J
$16.6B
$7.09M 0.01%
53,617
+9,491
+22% +$1.31M
ALGN icon
557
Align Technology
ALGN
$12.6B
$7.08M 0.01%
33,972
-5,506
-14% -$1.23M
NRIX icon
558
Nurix Therapeutics
NRIX
$2.51B
$7.06M 0.01%
374,673
+194,673
+108% +$4.46M
DNLI icon
559
Denali Therapeutics
DNLI
$3.82B
$7.06M 0.01%
346,304
AVY icon
560
Avery Dennison
AVY
$12.9B
$7.04M 0.01%
37,641
+2,881
+8% +$588K
DAL icon
561
Delta Air Lines
DAL
$58.8B
$7.01M 0.01%
115,931
-47,523
-29% -$2.81M
ARE icon
562
Alexandria Real Estate Equities
ARE
$9.41B
$6.98M 0.01%
71,561
+7,078
+11% +$776K
PFG icon
563
Principal Financial Group
PFG
$24.5B
$6.95M 0.01%
89,821
+134
+0.1% +$11.3K
EHC icon
564
Encompass Health
EHC
$11.5B
$6.94M 0.01%
75,174
+25,503
+51% +$2.5M
COO icon
565
Cooper Companies
COO
$14.1B
$6.92M 0.01%
75,225
-60,000
-44% -$6.11M
JBL icon
566
Jabil
JBL
$31.7B
$6.91M 0.01%
48,012
-1,545
-3% -$203K
UBS icon
567
UBS Group
UBS
$171B
$6.79M 0.01%
221,894
EQR icon
568
Equity Residential
EQR
$25.5B
$6.79M 0.01%
94,557
+13,888
+17% +$1.02M
RYAN icon
569
Ryan Specialty Holdings
RYAN
$5.96B
$6.77M 0.01%
105,490
+65,014
+161% +$4.53M
EVR icon
570
Evercore
EVR
$13.2B
$6.77M 0.01%
24,414
-4,613
-16% -$1.31M
FTI icon
571
TechnipFMC
FTI
$28.9B
$6.74M 0.01%
232,725
-6,805
-3% -$194K
PCAR icon
572
PACCAR
PCAR
$72.7B
$6.73M 0.01%
64,724
-22,497
-26% -$2.46M
AIZ icon
573
Assurant
AIZ
$14B
$6.73M 0.01%
31,546
-4,385
-12% -$912K
KEY icon
574
KeyCorp
KEY
$24.3B
$6.66M 0.01%
388,448
-26,958
-6% -$484K
APTV icon
575
Aptiv
APTV
$12.6B
$6.64M 0.01%
109,723
+16,700
+18% +$1.02M

Similar funds

Ensign Peak Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Ensign Peak Advisors held 1,743 positions worth $56.3B, down 1% from $56.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.1%. Ensign Peak Advisors opened 37 new positions and exited 34, leaving the 1,743-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

  • Ensign Peak Advisors's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 515,457 shares worth $302M.
  • Ensign Peak Advisors added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $156M increase.
  • Ensign Peak Advisors's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $374M.
  • Ensign Peak Advisors fully exited NewAmsterdam Pharma in Q4 2024, selling an estimated $4.08M.
  • Ensign Peak Advisors's ten largest holdings make up 32% of its $56.3B portfolio in Q4 2024.
  • Ensign Peak Advisors opened 37 new positions and closed 34 in Q4 2024.
  • Ensign Peak Advisors's portfolio value fell 1% quarter-over-quarter to $56.3B.

Based on Ensign Peak Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.